RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES

Clinical trials for RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES explained in plain language.

Never miss a new study

Get alerted when new RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES trials appear

Sign up with your email to follow new studies for RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

First-in-Human trial tests 'Living Drug' against deadly brain cancers

Disease control Ongoing

This early-stage study is testing the safety of a new cell therapy for adults with aggressive brain cancers that have spread to the lining of the brain and spinal cord. Doctors take a patient's own immune cells, genetically modify them in a lab to recognize and attack cancer cell…

Matched conditions: RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES

Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES

Get alerted when new RECURRENT METASTATIC MALIGNANT NEOPLASM IN THE LEPTOMENINGES trials appear

First-in-Human trial tests 'Living Drug' against deadly brain cancers